What is the HELP.NE share price today?

This page shows the latest available Helus Pharma Inc. (HELP.NE) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Helus Pharma Inc. listed?

Helus Pharma Inc. trades on Cboe Canada under the symbol HELP.NE, ISIN CA4234921076.

How large is Helus Pharma Inc.?

Its market capitalisation is approximately 924.21M CAD, based on the latest available price and share count from our data provider.

Cboe Canada · HELP.NE · ISIN CA4234921076

Helus Pharma Inc.

12.65 CAD

+0.79(+6.66%)

Previous close · Nov 6, 15:50 ET

Data last updated: Nov 6, 15:50 ET (2 d ago)· Delayed exchange data

Helus Pharma Inc. (HELP.NE) trades on Cboe Canada and operates in the Biotechnology industry. Its market capitalisation is approximately 924.21M CAD. The company reports around 100 employees. Its ISIN is CA4234921076. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Cboe Canada

ISIN

CA4234921076

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

924.21M CAD

Employees

100

Previous close

11.86 CAD

Day range

12.00 – 12.90

52-week range

5.30 – 20.88

Volume

10.62K

50-day average

16.40 CAD

200-day average

10.74 CAD

Asset type

Equity

About Helus Pharma Inc.

Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions. It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder; and HLP004, a deuterated N, N-dimethyltryptamine, which is in phase 2 clinical trial for treating generalized anxiety disorders. The company's preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluate HLP003 for the adjunctive treatment of major depressive disorder; and Osmind for mental health treatments. It operates in Canada, the United States, the United Kingdom, and Ireland. The company was formerly known as Cybin Inc. and changed its name to Helus Pharma Inc. in October 2026. Helus Pharma Inc. was founded in 2019 and is headquartered in Toronto, Canada.

Company website

Frequently asked

What is the HELP.NE share price today?: This page shows the latest available Helus Pharma Inc. (HELP.NE) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Helus Pharma Inc. listed?: Helus Pharma Inc. trades on Cboe Canada under the symbol HELP.NE, ISIN CA4234921076.
How large is Helus Pharma Inc.?: Its market capitalisation is approximately 924.21M CAD, based on the latest available price and share count from our data provider.

All Helus Pharma Inc. data comes from exchange and provider feeds for Cboe Canada and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.